Pharmacy Groups Praise CMS’ Progress on DIR Fee Reform to Lower Patients’ Out-of-Pocket Drug Costs

By |2018-11-27T17:12:16-05:00Nov-27-18|Categories: Press Release|Tags: , |

The National Community Pharmacists Association, the National Association of Chain Drug Stores, and the National Association of Specialty Pharmacy issued a statement regarding the Centers for Medicare & Medicaid Services’ release on Monday of the proposed rule titled “Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses."

House Sends NACDS-Backed “Gag Clause” Prohibition to President Legislation prevents restrictions on pharmacists’ ability to tell patients when they can save money on prescriptions by paying cash instead of using insurance;NACDS positions DIR fee reform as another crucial issue for lowering out-of-pocket drug costs

By |2018-09-25T17:03:37-05:00Sep-25-18|Categories: Press Release|Tags: , , |

The legislation will prevent restrictions on pharmacists’ ability to tell patients when they can save money on prescriptions by paying cash instead of using insurance. Meanwhile, NACDS positions DIR fee reform as another crucial issue for lowering out-of-pocket drug costs.

NACDS Leadership Details NACDS’ Value for Industry Transformation DIR fee reform, health-and-wellness expansion top Business Program agenda; NACDS communicates from Denver to Washington, D.C. about trade war’s risks

By |2019-03-19T14:49:16-05:00Aug-26-18|Categories: Press Release|Tags: , , , , , , , |

DIR fee reform, health-and-wellness expansion top Business Program agenda; NACDS communicates from Denver to Washington, D.C. about trade war’s risks.

NACDS Addresses DIR Fees, Other “Access Agenda” Priorities in National Drug-Pricing Policy Discussion NACDS responds to request-for-information from HHS Secretary Azar for “Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs”

By |2019-02-28T16:42:19-05:00Jul-18-18|Categories: Press Release|Tags: , , , , , , |

NACDS has submitted comments to Health and Human Services Secretary Alex Azar in response to the agency’s request-for-information on drug-pricing public policy issues.

NACDS RxIMPACT Rallies Senate Support for Action on DIR Fees Urging Senators to sign letter to HHS Secretary is the most recent action of NACDS’ grassroots advocacy program on this pressing issue

By |2019-02-28T16:45:00-05:00Jul-11-18|Categories: Press Release|Tags: , , , , , |

NACDS RxIMPACT pharmacy advocates are urging Senators to sign a letter to U.S. Secretary of Health and Human Services Secretary Alex Azar that is being led by Sen. Shelley Moore Capito (R-WV) and Sen. Jon Tester (D-MT).